ACTRN12617001625369招募中未知
Evaluating the feasibility of the Fear-Less Triple P 1/2 day workshop with parents of anxious children engaged with Disability Services.
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6 Years 至 —（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Preliminary evaluation of Fear-less Triple P for parents of anxiety-disordered childreAnxiety disorders in childrenMental Health - AnxietyACTRN12615000514505Vanessa Cobham60
已完成
不适用
Efficacy of delivering the Fear-less Triple P program at two differing levels of intensity for parents of children with anxiety disordersAnxiety disordersMental Health - AnxietyACTRN12615001284550Vanessa Cobham75
进行中（未招募）
1 期
A study of the safety and drug effects of levodopa inhalation powder (CVT-301) compared to Standard of Care Observational Cohort in patients with Parkinson’s diseaseEUCTR2014-003799-22-HUCivitas Therapeutics, Inc.365
进行中（未招募）
1 期
A study of the safety and drug effects of levodopa inhalation powder (CVT-301) compared to Standard of Care Observational Cohort in patients with Parkinson’s diseaseEUCTR2014-003799-22-CZCivitas Therapeutics, Inc.408
进行中（未招募）
1 期
A study of the safety and drug effects of levodopa inhalation powder (CVT-301) compared to Standard of Care Observational Cohort in patients with Parkinson’s diseaseParkinson's Disease With Motor Response Fluctuations (OFF Phenomena)MedDRA version: 19.0Level: LLTClassification code 10034007Term: Parkinson's disease NOSSystem Organ Class: 100000004852EUCTR2014-003799-22-DECivitas Therapeutics, Inc.408